References
- World Health Organisation. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. Geneva, Switzerland, 2009, http://www.who.int/substance_abuse/publications/opioid_dependence_guidelines.pdf. Accessed 28 May 2014
- Nicholls L, Bragaw L, Ruetsch C. Opioid dependence treatment and guidelines. J Manag Care Pharm 2010;16(1 Suppl B):S14-21. http://www.amcp.org/data/jmcp/S14-S21.pdf. Accessed 28 May 2014
- Stoops WW, Hatton KW, Lofwall MR, et al. Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potencies. Psychopharmacology (Berl) 2010;212:193-203
- Ling W, Mooney L, Hillhouse M. Prescription opioid abuse, pain and addiction: clinical issues and implications. Drug Alcohol Rev 2011;30:300-5
- Chandwani HS, Strassels SA, Rascati KL, et al. Estimates of charges associated with emergency department and hospital inpatient care for opioid abuse-related events. J Pain Palliat Care Pharmacother 2013;27:206-13
- Clark HW. Office-based practice and opioid-use disorders. N Engl J Med 2003;349:928-30
- Otiashvili D, Piralishvili G, Sikharulidze Z, et al. Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior-Outcomes of a randomized trial. Drug Alcohol Depend 2013;133:376-82
- Yokell MA, Zaller ND, Green TC, et al. Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review. Curr Drug Abuse Rev 2011;4:28-41
- McLellan AT, Lewis DC, O’Brien CP, et al. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000;284:1689-95
- Weiss RD, Potter JS, Fiellin DA, et al. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Arch Gen Psychiatry 2011;68:1238-46
- Cornish R, Macleod J, Strang J, et al. Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database. BMJ 2010;341:c5475
- Schackman BR, Leff JA, Polsky D, et al. Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care. J Gen Intern Med 2012;27:669-76
- Kaur AD, McQueen A, Jan S. Opioid drug utilization and cost outcomes associated with the use of buprenorphine-naloxone in patients with a history of prescription opioid use. J Manag Care Pharm 2008;14:186-94
- Baser O, Chalk M, Fiellin DA, et al. Cost and utilization outcomes of opioid-dependence treatments. Am J Manag Care 2011;17(8 Suppl):S235-48
- Barnett PG. Comparison of costs and utilization among buprenorphine and methadone patients. Stanford University, CA: Veterans Affairs Health Economics Resource Center and Department of Health Research and Policy, 2013
- Optum insight, clinformatics Data Mart. http://www.optuminsight.com/life-sciences/solutions/value-strategy/marketing-analytics/clinformatics-data-mart/~/media/Ingenix/Life_Sciences/Documents/OptumInsightLifeSciencesClinformaticsDataMart_old.pdf. Accessed 24 May 2014
- The National Center for Health Statistics (NCHS) and the Centers for Medicare and Medicaid Services. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). http://www.cdc.gov/nchs/icd/icd9cm.htm. Accessed 28 May 2014
- Medicare Fee-for-service. http://www.cms.gov/Medicare/Coding/ICD10/Medicare-Fee-for-Service-Provider-Resources.html. Accessed 28 May 2014
- First Databank. http://www.fdbhealth.com/. Accessed 28 May 2014
- SAS Institute Inc. SAS V9.3. Cary, NC: SAS Institute Inc, http://support.sas.com/software/93/. Accessed 28 May 2014
- Strain EC, Stitzer ML, Liebson IA, et al. Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users. Psychopharmacology (Berl) 1994;116:401-6
- Zah V, Clay E, Aballea S, et al. Patient persistence with Buprenorphine/Naloxone Film and tablet formulations in the treatment of opioid dependence in the United States: results from a privately insured retrospective database, Association for Medical Education and Research in Substance Abuse, 36th Annual National Conference, Bethesda, Maryland, 2012